Home › Funds › Catalio Capital Management, LP › TARA

Catalio Capital Management, LP position in TARA

PROTARA THERAPEUTICS INC · Health Care

Catalio Capital Management, LP reported holding 520,148 shares of TARA (PROTARA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.0M, representing 0.37% of its reported portfolio and ranking #34 among its reported holdings. Catalio Capital Management, LP has disclosed TARA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)520.15K sh
Reported value held$1.99M
Portfolio Weight0.37%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's TARA position evolved

Catalio Capital Management, LP first disclosed a stake in TARA in Q4 2024 at 1,088,691 shares (US$5.7M). The position peaked in Q4 2025 at 1,446,254 shares, worth US$7.7M. Across 7 filings, Catalio Capital Management, LP increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 520,148 shares valued at US$2.0M — a reduction of -59,876 shares quarter over quarter.. Notable position changes include a 49% increase in Q2 2025 (shares rose 44% over the following quarter), a 60% trim in Q1 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.09M $5.75M New
Q1 2025 1.09M $4.64M Hold
Q2 2025 1.63M $4.93M Add
Q3 2025 1.50M $6.53M Reduce
Q4 2025 1.45M $7.71M Reduce
Q1 2026 580.02K $3.02M Reduce
Q2 2026 520.15K $1.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TARA and 13F data

TARA (PROTARA THERAPEUTICS INC) is a Health Care company. 49 other funds we track also report a position in TARA — the largest reported positions include Velan Capital Investment Management LP (US$10.9M), Sio Capital Management, LLC (US$7.3M), ACORN CAPITAL ADVISORS, LLC (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TARA

All TARA fund holders →

FAQ

How long has Catalio Capital Management, LP held TARA?

Catalio Capital Management, LP has disclosed TARA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Catalio Capital Management, LP's current position in TARA?

As of Q2 2026, Catalio Capital Management, LP holds 520.15K shares of TARA (PROTARA THERAPEUTICS INC), valued at $1.99M, representing 0.37% of its reported portfolio and ranking #34.

Has Catalio Capital Management, LP been buying or selling TARA?

In the latest 13F filing (Q2 2026), Catalio Capital Management, LP reduced its position in TARA. The position peaked in Q4 2025 at 1.45M shares.

Which other funds hold TARA?

Other major institutional holders of TARA include Velan Capital Investment Management LP, Sio Capital Management, LLC, ACORN CAPITAL ADVISORS, LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.